Comparison of Radiofrequency Ablation and Transarterial Chemoembolization for Hepatocellular Carcinoma in the Caudate Lobe
- 26 June 2018
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 41 (11) , 1699-1707
Abstract
Hepatocellular carcinoma (HCC) in the caudate lobe is technically challenging for both radiofrequency ablation (RFA) and transarterial chemoembolization (TACE). However, each of these modalities has its strengths. This retrospective study compares the effectiveness of RFA and TACE in patients with caudate HCC within the Milan criteria.Keywords
This publication has 28 references indexed in Scilit:
- Recent advances of radiofrequency ablation for early hepatocellular carcinomaJournal of Gastroenterology and Hepatology, 2011
- Radiofrequency Ablation for Hepatocellular Carcinoma: Updated Review in 2010Oncology, 2010
- Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?Hepatology, 2007
- A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular CarcinomaAnnals of Surgery, 2006
- Surgical outcome of patients with hepatocellular carcinoma originating in the caudate lobeThe American Journal of Surgery, 2005
- Limited Hepatic Resection for Hepatocellular Carcinoma in the Caudate LobeWorld Journal of Surgery, 2004
- Surgical strategy for hepatocellular carcinoma originating in the caudate lobeSurgery, 2004
- Resection of Hepatocellular Carcinoma in Patients Otherwise Eligible for TransplantationAnnals of Surgery, 2003
- Surgical Treatment of Hepatocellular Carcinoma Originating from the Caudate LobeWorld Journal of Surgery, 1996
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisNew England Journal of Medicine, 1996